Intelligent Bio-Systems
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Intelligent Bio-Systems - overview
Established
2005
Location
Waltham, MA, US
Primary Industry
Medical Devices & Equipment
About
Intelligent Bio-Systems specializes in bioinformatics, offering innovative data analysis solutions tailored for life sciences, enhancing the management of biological data for improved research outcomes. Founded in 2005 in Waltham, US, Intelligent Bio-Systems focuses on bioinformatics solutions. The company has undergone a strategic pivot over the years to enhance its product offerings. In June 2012, Qiagen acquired Intelligent Bio-Systems for undisclosed terms.
The firm has engaged in 4 notable deals to date, with its most recent funding round being a Series A round in which they raised USD 0. 35 mn from Hub Angels Investment Group and Kegonsa Capital Partners, bringing the total amount raised to USD 0. 35 mn. IntelligentBioSystems.
com provides a variety of solutions in bioinformatics and life sciences, primarily focusing on advanced data analysis and management for biological data. Their main product offerings help integrate and interpret genomic and proteomic data, facilitating efficient analysis for research laboratories, biotech firms, and academic institutions. These solutions support customers in North America and Europe, addressing the growing need for high-resolution biological data analysis. IntelligentBioSystems.
com generates revenue through software licensing and subscription services, offering clients flexible access to their bioinformatics solutions. Clients typically enter into annual or multi-year agreements for software licenses, which allow access to necessary tools and updates for scientific research. Pricing varies based on service scope and active users, accommodating both small laboratories and larger institutions. Looking ahead, Intelligent Bio-Systems aims to launch new bioinformatics products tailored for emerging trends in genomic research, with anticipated releases in the coming year.
The company is targeting expansion into the Asian market by 2025, looking to engage new clients in regions currently underrepresented. The funding raised in June 2012 will be utilized to support these new product developments and market expansions.
Current Investors
Kegonsa Capital Partners, Hub Angels Investment Group
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.intelligentbiosystems.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.